Test group:Apatinib combined with TACE

2 trials

Sponsors

Jiangsu Cancer Hospital, Zhongda Hospital,Affiliated to Southeast University

Conditions

Hepatocellular Carcinomaadvanced primary liver cancer who can't be?removed surgically

Unknown Phase

Apatinib combined with TACE approach in the treatment of patients with unrecectable advanced primary liver cancer: a multicenter, randomized, controlled, exploratory study

RecruitingChiCTR-IOR-17010637

Jiangsu Cancer Hospitaladvanced primary liver cancer who can't be?removed surgically

Start: 2017-02-15Updated: 2017-04-18

Study of the combination of TACE with Apatinib in Patients with Hepatocellular Carcinoma Trial

RecruitingChiCTR-IOR-17010925

Zhongda Hospital,Affiliated to Southeast UniversityHepatocellular Carcinoma

Start: 2017-03-19Updated: 2017-04-18